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Abstract
Background: Biomarkers of biological aging – DNA methylation age (DNAm age) and leukocyte telomere length
(LTL)– correlate strongly with chronological age across the life course. It is, however, unclear how these measures of
cellular wear and tear are associated with muscle strength and functional capacity, which are known to decline
with older age and are associated with mortality. We investigated if DNAm age and LTL were associated with body
composition and physical functioning by examining 48 monozygotic twin sisters.
Methods: White blood cell DNAm age (predicted years) was calculated from Illumina 450 k BeadChip methylation
data using an online calculator. DNAm age acceleration was defined from the residuals derived from a linear
regression model of DNAm age on chronological age. LTL was measured by qPCR. Total body percentage of fat
and lean mass were estimated using bioimpedance. Physical functioning was measured by grip strength, knee
extension strength and by 10 m maximal walking speed test.
Results: In all participants, DNAm age (58.4 ± 6.6) was lower than chronological age (61.3 ± 5.9 years). Pairwise correlations
of monozygotic co-twins were high for DNAm age (0.88, 95% CI 0.79, 0.97), age acceleration (0.68, 95% CI 0.30, 0.85) and LTL
(0.77, 95% CI 0.60, 0.94). Increased age acceleration i.e. faster epigenetic aging compared to chronological age was
associated with lower grip strength (β=− 5.3 SE 1.9 p= 0.011), but not with other measures of physical functioning or body
composition. LTL was not associated with body composition or physical functioning.
Conclusions: To conclude, accelerated DNAm age is associated with lower grip strength, a biomarker known to be
associated with physiological aging, and which predicts decline in physical functioning and mortality. Further studies may
clarify whether epigenetic aging explains the decline in muscle strength with aging or whether DNAm age just illustrates
the progress of aging.
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Background
Many theories have emerged to explain the processes or
mechanisms driving aging. It is well known that aging
and especially longevity has a genetic component [1],
and some environmental factors such as infections, diet,
alcohol use, smoking and work exposures predispose to
age-related diseases and increase probability of death.
However, only a small fraction of individual variation to
life expectancy can be accounted for using known and
measured characteristics and exposure. Biological clocks
may increase our understanding on human aging [2].
DNA methylation (DNAm) age [3] and telomere length
[4] are timely and interesting biological clocks, which
may provide insights into the mechanisms behind why
some individuals age faster than others and are more
prone to age-related diseases and accelerated decline in
physical functioning (Fig. 1).
Epigenetic changes affect the function of DNA without
altering the genetic code itself. Epigenetic regulation
modifies the function of genetic information by control-
ling when specific genes are switched on or off, for ex-
ample during development or aging. DNAm is one type
of epigenetic modification, which changes over time.
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The most promising estimate for biological age devel-
oped from DNAm data is Steve Horvath’s DNAm age,
also known as “Epigenetic clock” [3]. DNAm age is an
age estimate based on DNA methylation at 353 specific
CpG sites. DNAm age increases over chronological age,
but it is not yet clear if it is only a marker of biological
aging or has an effect on aging per se [3].
Telomeres are short DNA sequences located at the
end of the eukaryotic chromosomes protecting func-
tional DNA. In most somatic cells, such as in leukocytes,
telomerase activity is low and telomeres shorten with
every cell cycle. This is due to the inability of DNA poly-
merase to fully replicate chromosome ends leading to
replicative senescence and apoptosis [5]. Oxidative stress
enhances telomere erosion with cell replication [6],
whereas inflammation entails an increase turnover of
leucocytes [7]. Telomere length can be used as an indi-
cator of cells replicative history and regenerative poten-
tial and, therefore, it might serve as an indicator of
biological age [8].
Both DNAm age and telomere length are highly herit-
able [3, 9]. Few studies done so far have suggested that
these biological age estimates are uncorrelated and
therefore appear to be tagging different aspects of the
aging process [2]. Faster running clock i.e. shorter telo-
meres or higher DNAm age compared to chronological
age are associated with declining physical function with
aging [10–12], and predict higher mortality risk [2, 13].
Of several age-related physiological changes, decline in
muscle mass and strength are the most important factors
in regards to physical functioning and quality of life.
Muscle strength loss with aging together with adverse
changes in body composition predispose to several age-
related diseases and to decline in physical functioning,
mobility and loss of independence. However, muscle
strength and mass are well-preserved in some individuals
up till old age, while others suffer from accelerated decline
during aging. The purpose of the present study was to in-
vestigate if novel biological clocks (DNAm age and LTL)
can explain interindividual variation in body composition
and physical functioning in 54 to 72 year-old women.
Methods
Participants and study design
The participants originate from two studies: 1) “Sarcopenia -
Skeletal Muscle Adaptation to Postmenopausal Hypogonad-
ism and Effects of Hormone Replacement Therapy and
Physical Activity in Older Women: a Genetic and Molecular
Biological Study on Estrogen-related Pathways”
(SAWEs, n = 15 pairs) and the Finnish Twin Study on
Aging (FITSA, n = 9 pairs). Participants of both these
studies were recruited from the Older Finnish Twin
Cohort [14, 15] and the recruitment process has been
described in detail elsewhere [16, 17]. Briefly, SAWEs
twins were recruited for laboratory visit based on
discordance for long term hormone replacement ther-
apy (HRT), while FITSA participants participated on
laboratory visit within study investigating the role of
genetic and environmental factors in the disablement
process in old age and HRT discordant pairs were se-
lected from larger population afterwards. Altogether
24 monozygotic Caucasian twin pairs discordant for
long term HRT were investigated. HRT users and
their co-twins did not differ in regards to biological
clocks, body composition or physical functioning
(Additional file 1: Table S1). Twins were similar in
their physical activity habits, daily energy intake, use
of medication, and smoking behavior [17, 18].
DNA methylation age and age acceleration
High molecular weight white blood cell DNA was ex-
tracted using QIAamp DNA Mini Kit (QIAGEN, Nordic,
Sollentuna, Sweden). Bisulfite conversion of DNA was
completed using EZ-96 DNA methylation-Gold Kit
(Zymo Research, Irvine, CA, USA) according to the
manufacturer’s instructions, and the co-twins were al-
ways converted on the same plate to minimize potential
batch effects. Genome-wide DNAm was measured using
Illumina’s Infinium HumanMethylation450 BeadChip ac-
cording to the manufacturer’s instructions. The Illumina
BeadChips measure single-CpG resolution DNAm levels
at 485577 CpG sites across the human genome. DNAm
age was calculated from 353 specific CpG-sites known
to be associated with aging based on their methylation
using validated algorithm and online tool [3]. Age accel-
eration, which describes the difference between chrono-
logical age and DNAm age (“faster or slower biological
aging”) was calculated for all subjects as the residuals
from a linear regression model of DNAm age on
chronological age.
Fig. 1 Association between grip strength and DNA methylation age
acceleration in the total group of subjects (n = 48)
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Telomere length measurements
Quantitative real-time polymerase chain reaction (qPCR)
based method was used determine relative LTL from per-
ipheral blood DNA [12]. Details of the analysis as well as
quality control procedures have been reported earlier [12,
19]. Briefly, a separate qPCR reaction was performed with
telomere sequence-specific primers and a single copy con-
trol gene, β-hemoglobin (HBB). Quality control and calcula-
tion of the T/S (telomere to single-copy gene intensity)
ratios for the samples to obtain the relative telomere length
was performed with Bio-Rad CFX Manager v.1.6 software.
The coefficient of variation for repeated measures was 6.
37% for the telomere reaction, 4.99% for the HBB reaction,
and 6.97% for the ratio (T/S). Telomere length measure-
ment was available from 45 of the 48 twin sisters.
Body composition
Body mass index (BMI) was calculated from measured
body weight and height (kg/m2). Total body percentage of fat
and lean mass (LM) were estimated using bioimpedance
(Spectrum II, RJL Systems, Detroit, MI, USA).
Physical functioning
Grip strength (N) was measured using an isometric dyna-
mometer (Good Strength IGS01, Metitur Oy, Jyväskylä,
Finland). Best attempt of three maximal trials was used in
the analysis.
Knee extension strength (N) was measured using an
adjustable dynamometer chair (Good Strength, Metitur,
Palokka, Finland). Knee extension strength was mea-
sured at the knee angle of 60° from full extension with
the ankle fastened by a belt to a strain-gauge system.
After familiarization, three to five maximal efforts, sepa-
rated by a 1-min rest, were conducted. For each subject,
the best performance with the highest value was ac-
cepted as the result.
Maximal walking speed over 10 m was recorded with
photocells placed 71 cm from ground level and using a
Digitest-1000 amplifier-time measurement system (Digi
Test-1000; Digitest Ltd., Muurame, Finland). The start
position was 50 cm from the photocell line and the end-
point was 10 m away from the first photocell line [17].
Statistics
Data are shown as means and standard deviations unless
otherwise stated. Intraclass correlation coefficients (ICC)
were computed for the twin pairs to estimate the level of
within-pair similarity. Associations between chronological
age, DNAm age, age acceleration and LTL (adjusted for
age) were analyzed using standardized regression coeffi-
cients to represent bivariate correlations. Age adjusted asso-
ciations between biological clocks and body composition
and physical functioning were tested with regression ana-
lyses. Within-pair dependency of twin individuals was taken
into account using the cluster option in the analyses. HRT
was also considered as a potential confounder, but it had
no effect to the models (data not shown). The level of sig-
nificance was set at p ≤ 0.05. Data analyses were carried out
with R version 3.2.2 with RStudio version 0.98.932 (R Core
Team 2015).
Results
Participants’ characteristics
The mean age of the participants (61.3 ± 5.9 years) was
slightly higher than predicted by DNAm age (58.4 ± 6.
8 years) (Table 1).
Within-pair analysis showed that the twin sisters were
highly similar for their DNAm age, age acceleration, and
LTL (r= 0.88, 95% CI 0.79–0.97; r= 0.68, 0.39–0.85; r= 0.77,
0.60–0.94, respectively). Moderate within-pair correlations
were also observed for percentage of fat (0.64, 0.33–0.83),
lean mass (0.60, 0.27–0.80) and knee extension
strength (r= 0.62, 0.30–0.81), while weaker and non-
significant associations occurred for grip strength (r= 0.27,
− 0.024−0.67) and walking speed (r= 0.19,−0.23–0.55). Stan-
dardized correlation coefficient between chronological age
and DNAm age was 0.79 (p < 0.001). However, chronological
age did not correlate with LTL (r=− 0.17, p= 0.34). DNAm
age acceleration was not associated with LTL, when LTL was
adjusted for age (residuals) (r=− 0.29, p= 0.059).
Higher age acceleration was associated with higher
total body lean mass and lower grip strength, but not
with percentage of fat, knee extension strength or walk-
ing speed (Table 2, Fig. 1). LTL was not associated with
body composition or physical functioning in age ad-
justed models (Table 3).
Discussion
Biological aging process is dependent on our inherited gen-
etic background and shaped by multiple environmental,
Table 1 Subject characteristics
Variable Mean (SD)
Age 61.3 (5.9)
Biological clocks
DNAm age (predicted years) 58.4 (6.8)
Age acceleration 0.00 (4.2)
Leukocyte telomere length 0.91 (0.15)
Body composition
Percentage of fat (%) 32.6 (7.7)
Lean mass (kg) 47.8 (3.8)
Physical functioning
Grip strength (N) 233 (64)
Knee extension strength (N) 389 (91)
Walking speed 10 m (s) 6.5 (1.0)
SD standard deviation, DNAm DNA methylation
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social and lifestyle factors leading to great diversity in life
span, and older age health and physical functioning. This
diversity within countries is found even in those well-
developed, peaceful and wealthy societies that have mini-
mized many external agents affecting average lifespan such
as infections, poor living conditions, poverty and unstable
civil society. These latter factors account for much of the
average differences between countries globally. Even in less-
developed countries, the majority of morbidity comes from
non-communicable diseases, which have many common
determinants (such as tobacco use, alcohol, diet and phys-
ical inactivity). Many of these common proximal factors
have more distal psychological and social determinants, in-
dicating a complex network of causation superimposed on
the natural biology of our species for development and
ageing.
Biological clocks may give insights into why some in-
dividuals age at faster rates compared to others, and are
therefore more prone to adverse effects of aging, such as
loss of muscle strength and mass, which further leads to
loss of physical functioning and increased incidence of
diseases. This study compared two widely used bio-
logical aging clocks, and their associations with trad-
itional measures of physiological aging; muscle mass and
physical function. The results suggest strong familial
component to both LTL and DNAm age estimates, pos-
sibly due to strong genetic effects. Our study shows that
the novel epigenetic aging marker, DNAm age,
compared to LTL, holds more potential in tracking indi-
vidual variation in physical function with aging.
Multiple biomarkers have been tested to evaluate and
to predict individual aging. Shorter LTL compared to
mean LTL length in cohorts at certain chronological age
predicts morbidity and mortality [20]. Also higher
DNAm age compared to chronological age predicts mor-
tality risk [2, 13]. Despite these similarities, recent
evidence suggests that DNAm age estimate describes
cellular aging mechanism that is independent of DNA
damage induced senescence and telomere length [21].
Our results support these findings showing no signifi-
cant associations between LTL and Horvath’s DNAm
age acceleration, while a high precision with DNAm age
and chronological age was observed.
The observed within-pair correlation in LTL among
monozygotic twins pairs agree with earlier findings [9, 22]
suggesting strong effect of familial factors. In general, earlier
studies have reported at most weak associations between
LTL and physical function [23, 24]. Despite including mul-
tiple different measures of physical functioning in the
current study, we also did not observe cross-sectional asso-
ciations between LTL and physical functioning. Although it
must be noted that our sample size is limited, the model
parametric do not support existence of associations.
However, it is possible that LTL predicts future develop-
ment of adverse aging effects. We have recently shown that
LTL predicts loss of physical function during an 11-year
Table 2 Associations between body composition, physical functioning and age acceleration in all subjects (n = 48)
Coefficients Model 95%CI
β s.e. p R2 lower upper
Body composition
Lean mass (kg) 0.335 0.15 0.041 0.137 0.033 0.638
Fat percent (%) 0.376 0.30 0.225 0.042 −0.214 0.967
Physical performance
Hand grip strength (Nm) −5.324 1.91 0.011 0.121 −9.076 −1.573
Walking speed 10 m (s) −0.029 0.03 0.397 0.016 −0.096 0.037
Knee extension (Nm) −3.234 3.36 0.346 0.022 −9.817 3.349
All p-values are assessed with linear regression
Table 3 Associations between body composition, physical functioning and leukocyte telomere length age in all subjects (n = 45)
Coefficients Modela 95%CI
β s.e. p R2 lower upper
Body composition
Lean mass (kg) −4.533 4.27 0.301 0.032 −12.906 3.841
Fat percent (%) −10.406 12.10 0.400 0.040 −34.115 13.302
Physical performance
Hand grip strength (Nm) 69.630 64.05 0.290 0.045 −55.912 195.164
Walking speed 10 m (s) −0.917 0.75 0.237 0.147 −2.391 0.558
Knee extension (Nm) −18.794 74.63 0.804 0.215 − 165.071 127.482
All p-values are assessed with linear regression. a Model fit statistics are shown for the covariate and adjusting covariate (age). s.e., standard error
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follow-up in older women [12], and that LTL is causally as-
sociated with cognitive function [25].
Muscle strength reaches its peak at age of 20 to
30 years and declines slowly thereafter [26]. After 50’s
muscle strength loss accelerates leading to walking limi-
tations, loss of function and increased disabilities and
morbidity. Although strength loss is a universal aging ef-
fect, both peak strength level and strength decline are
shaped by genetic background and multiple environmen-
tal factors leading to great diversity in physical function-
ing in older age. DNAm age may offer fresh perspectives
into mechanisms that lead to this individual variation,
but current evidence is limited [10]. In line with a previ-
ous study [10], we found that individuals with faster bio-
logical aging have lower grip strength. It is possible that
an unknown cellular mechanism behind aging is affected
by the biological aging markers as multiple studies have
shown that grip strength has a very high predictive value
in terms of incidence of functional limitations, morbidity
and mortality in later life [26–28]. However, longitudinal
and mechanistic studies are needed to elucidate and
characterize potential causal mechanisms. Age acceler-
ation was not associated with knee extension strength
and walking speed. These measures of physical function
include larger inter-individual variation and are affected
by multiple confounders, such as body size and physical
activity, and therefore do not reflect physiological aging
as purely as decline in grip strength.
Twin studies have confirmed that the effect of familial
factors is large in physical functioning and body lean
mass. Large scale genome-wide association studies have
not been published for many traits related to physical
functioning, and only a minor fraction of underlying
genetic factors has been attributed to specific genes or
genotypes [29]. The genetic architecture of body com-
position is better known, in particular of height, overall
BMI and regional adiposity [30, 31], and much of their
heritability is accounted for identified genes [32]. It is
not known, what is the role of epigenetic factors, such as
DNAm, in this “hidden heritability” [33]. This study re-
vealed minor or non-existent associations between body
composition and DNAm age acceleration. We found a
positive association between DNAm age acceleration
and total body lean mass. This result may be partly ex-
plained by the fact that body fat and lean mass at the
total body level often increases slowly over adult age,
even though muscle mass in lower extremities often
decreases over adult age, similarly as muscle strength.
Another explanation for this finding is rather narrow
distribution in lean mass among the study sample, as
subjects with severe morbidity, sarcopenia or frailty
were not included in the study. In addition, our study
subjects represent a sample of rather young same-sex
individuals.
Studies on body composition and telomere length
have relied almost exclusively on indirect anthropo-
metric measures such as BMI [34]. We used the
bioimpedance method for establishing body compos-
ition, and were able to test for associations of per-
centage of fat and lean mass with biological aging
separately, but did not observe any significant associa-
tions. It has been speculated that body composition
and especially obesity may affect telomere attrition
through multiple mechanisms, but studies have re-
ported very inconsistent results [34]. Most likely asso-
ciations between telomere shortening in adulthood
and old age has very minor effects in poorly prolifer-
ating tissues such as fat or muscle tissue.
In this study aging biomarkers were analyzed using
blood samples rather than muscle tissue, which may be
more relevant tissue in terms of physical function.
Telomere length varies depending on the sample origin
and telomeres from different tissues may have divergent
associations with the amount and distribution of body
fat and muscle mass [19]. Also different tissues in the
same individual may vary in terms of their DNAm age
[3]. Aging of the liver, rather than blood, muscle or fat
tissue, is accelerated in obese subjects [35]. Muscle tis-
sue is the key tissue affecting age-related decline in
physical functioning, several age-related diseases such as
type II diabetes and cardiovascular diseases, and even
mortality [36, 37]. At least two studies have reported
modest to high correlations between DNAm age in
muscle tissue and chronological age [3, 35]. However,
none of these studies have investigated DNAm age of
the muscle tissue in association with physical functioning.
Future studies examining DNAm age in muscle tissue
may hold potential for identifying genes, pathways, and
regulatory mechanisms of importance for disease develop-
ment and age-related decline in physical functioning.
Monozygotic female twin pairs were used in this study,
resulting in limited sample size, which in turn may re-
duce the credibility when generalizing our results to
general population. The ICCs in monozygotic twin pairs
estimate the proportion of familial factors in the vari-
ables under investigation. However, these correlations
provide only an upper limit to the heritability although
the relative roles of genetic and shared environmental
factors cannot be teased apart. The strength of our study
was that physical function measurements were per-
formed by experienced research personnel and in stan-
dardized laboratory settings. Some criticism has been
leveled about rationale and measurements of both aging
biomarkers that were investigated in this study. Quanti-
tative real-time PCR method used in this study to meas-
ure LTL has been validated and is widely used [38].
Although DNAm age is a relatively new biomarker of
aging, and it is not known what it really captures [3, 35],
Sillanpää et al. BMC Geriatrics  (2018) 18:83 Page 5 of 7
it has been shown to correlate highly with chronological
age and to be associated with multiple aging related phe-
notypes and diseases [10, 35]. However, there are several
estimates for quantification of biological age from
DNAm data, and some of these may be more consist-
ently related to phenotypes related to physical function-
ing [39].
Conclusions
This study support earlier findings that DNAm is associ-
ated with biological aging [10]. DNAm age acceleration
seems to share similar individual age trajectories with
grip strength, which is a strong predictor of development
of older age disabilities and mortality [26–28, 40]. Further
studies are required to establish whether DNAm regulates
aging pathways related to physical function or whether it
is just a biomarker that correlates highly with grip
strength and chronological age.
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